ETC
HRMY icon

Exchange Traded Concepts’s Harmony Biosciences HRMY Stock Holding History

Exchange Traded Concepts’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Buy
87,891
+879
+1% +$27.7K 0.01% 577
2026
Q1 		$2.44M Buy
87,012
+29,539
+51% +$969K 0.02% 557
2025
Q4 		$2.15M Sell
57,473
-7,550
-12% -$248K 0.02% 579
2025
Q3 		$1.79M Buy
65,023
+32,923
+103% +$1.13M 0.02% 602
2025
Q2 		$1.01M Buy
32,100
+1,844
+6% +$59.3K 0.01% 678
2025
Q1 		$1M Buy
+30,256
New +$1.08M 0.02% 560
2024
Q3 		– Sell
-28,393
Closed -$857K – 1370
2024
Q2 		$857K Buy
28,393
+1,668
+6% +$50.2K 0.02% 489
2024
Q1 		$897K Sell
26,725
-14,164
-35% -$455K 0.02% 460
2023
Q4 		$1.32M Buy
40,889
+328
+0.8% +$9.15K 0.04% 340
2023
Q3 		$1.33M Buy
40,561
+40,163
+10,091% +$1.39M 0.04% 308
2023
Q2 		$14K Sell
398
-7
-2% -$242 ﹤0.01% 1187
2023
Q1 		$13.2K Buy
+405
New +$18.4K ﹤0.01% 994

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exchange Traded Concepts's HRMY Position: Q2 2026 in Review

Exchange Traded Concepts increased its Harmony Biosciences (HRMY) stake by 1% in Q2 2026, buying an estimated $27.7K and bringing the position to 87,891 shares worth $3.2M. The position accounts for 0.01% of the portfolio, ranked #577.

Exchange Traded Concepts first reported a position in HRMY in Q1 2023 and has held it in 12 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Exchange Traded Concepts held 87,891 shares of Harmony Biosciences worth $3.2M as of Q2 2026.
  • Exchange Traded Concepts bought 879 Harmony Biosciences shares in Q2 2026, an estimated $27.7K.
  • Harmony Biosciences made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #577 holding.
  • Exchange Traded Concepts first reported a position in Harmony Biosciences in Q1 2023 and has held it in 12 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.